Table 6.

Profiles of internalizing trajectory groups weighted by probability of group membership

	Internalizing Symptoms
	Group 1	Group 2	Group 3	Group 4	Unweighted Total
Characteristic T7–T9	M (SD)	M (SD)	M (SD)	M (SD)	M (SD)
Medication use
No. of nonpsychotropic	1.14 (1.25)	1.17 (1.34)	1.10 (1.41)	1.10 (1.30)	1.14 (1.49)
No. of psychotropic	1.22 (1.19)	1.31 (1.18)	1.27 (1.21)	1.91 (1.34)	1.33 (1.26)
No. of mental health diagnoses	0.85 (1.14)	1.13 (1.14)	1.32 (1.09)	2.36 (1.23)	1.18 (1.21)
Anxiety	0.26 (0.44)	0.40 (0.49)	0.53 (0.50)	0.80 (0.41)	0.41 (0.49)
Depression	0.06 (0.25)	0.11 (0.31)	0.13 (0.34)	0.63 (0.49)	0.14 (0.35)
ADD/ADHD	0.20 (0.41)	0.20 (0.40)	0.23 (0.43)	0.25 (0.44)	0.21 (0.41)
OCD	0.27 (0.45)	0.34 (0.48)	0.36 (0.49)	0.49 (0.51)	0.33 (0.47)
Schizophrenia	0.00 (0.00)	0.01 (0.09)	0.02 (0.16)	0.09 (0.29)	0.02 (0.13)
Bipolar disorder	0.06 (0.03)	0.09 (0.03)	0.08 (0.04)	0.20 (0.09)	0.09 (0.28)
Coresidence	0.35 (0.48)	0.47 (0.50)	0.43 (0.50)	0.28 (0.46)	0.40 (0.49)

Note: T7–T9, Time 7–Time 9; ADD/ADHD, Attention-deficit disorder/attention-deficit/hyperactivity disorder; OCD, obsessive compulsive disorder; coresidence, in parental home.